Condition
Hodgkin Lymphoma in Remission clinical trials and research
Research outlook What's coming for Hodgkin lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Hodgkin Lymphoma in Remission clinical trials that are recruiting, at sites in 5 countries (most in Italy (1), Australia (1), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Evaluating biological aging markers in Hodgkin's lymphoma patients
This study is trying to see if certain biological markers can help us understand how aging affects people with Hodgkin's lymphoma who are in remission or newly diagnosed.
-
Effects of dexrazoxane on heart health in cancer survivors
This study tests if the drug dexrazoxane can help protect the heart health of cancer survivors who had leukemia, lymphoma, or osteosarcoma.
Related topics
Quick answers
How many Hodgkin Lymphoma in Remission clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Italy (1 trial), Australia (1 trial), Canada (1 trial), Puerto Rico (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.